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Abstract 
 
 
Each month, the endometrium undergoes a cyclic process of proliferation and 
differentiation establishing the basis for a successful pregnancy. Due to a tight 
modulation between gonadotrophins, pituitary and ovarian hormones, the endometrium 
only becomes receptive in a specific “window of implantation”. During this time, 
endometrial stromal cells differentiate into decidual cells, which control trophoblast 
invasion, regulate immune responses and restrain the oxidative stress. Nowadays, 
there is an emergent research area that links the endocannabinoid system with key 
events for a successful pregnancy. The main endocannabinoid, anandamide (AEA), 
has been described to be involved in folliculogenesis, embryo transport, decidualization 
and placental development. Although it is known that endocannabinoids are involved in 
rat decidual remodelling, it is not clear the impact of these lipids mediators on human 
endometrial stromal cell proliferation and differentiation. Thus, this work aims to fill this 
gap in scientific knowledge by studying the morphological and biochemical effects of 
AEA on human endometrial stromal cells. AEA induced an apoptotic and anti-
proliferative effect on non-differentiated cells. On the other hand, AEA also led to the 
presence of binucleate cells and prevented the process of differentiation. Altogether, 
this suggests that AEA may be enrolled in the regulation of endometrial remodelling, 
and thus, interfere with pregnancy establishment. 
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Resumo 
 
 
O endométrio sofre um processo cíclico de proliferação e diferenciação 
constituindo a base para uma gravidez de sucesso. A modulação entre as hormonas 
do hipotálamo, hipófise e ovário determinam a recetividade do endométrio durante um 
período específico denominado por “janela de implantação”. As células do estroma do 
endométrio diferenciam-se em células deciduais, que controlam a invasão dos 
trofoblastos, a resposta imunitária e a defesa contra o stress oxidativo. A investigação 
do sistema endocanabinóide emergiu nos últimos anos e relaciona este com os 
processos essenciais para uma gravidez bem sucedida. O principal endocanabinóide, 
a anandamida (AEA), parece estar envolvido na maturação folicular, no transporte do 
embrião, na decidualização e no desenvolvimento da placenta. Embora os 
endocanabinóides estejam envolvidos na remodelação decidual do rato, ainda não é 
claro o impacto destes mediadores lipídicos na proliferação e diferenciação das 
células do endométrio humano. Assim, este trabalho tem como objetivo colmatar esta 
falha no conhecimento científico através do estudo dos efeitos morfológicos e 
bioquímicos da AEA nas células do estroma uterino. A AEA induziu um efeito 
apoptótico e anti-proliferativo nas células endometriais não diferenciadas. Por outro 
lado, a AEA também levou ao aparecimento de células binucleadas e preveniu o 
processo de diferenciação. Estes resultados sugerem que a AEA poderá participar na 
regulação da remodelação endometrial e por conseguinte interferir com o 
desenvolvimento de uma gravidez de sucesso.   
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I Introduction 
 	  
1 Endometrium 
The endometrium is the mucosa that lines the lumen of the uterus. It is 
composed of two distinct layers. The luminal functional layer (stratum functionalis) 
contains	  glands lined with columnar epithelium that extend from the surface epithelium 
and a loose stroma, while the basal layer (stratum basalis) adjacent to the 
myometrium comprises the bases of the endometrial glands surrounded by dense 
stroma (1). In every menstrual cycle, the upper functional layer proliferates, secretes 
and sheds, while the lower basal layer is permanent and provides cells for generating a 
new functional layer (2).  
During the reproductive phase, the endometrium becomes a highly dynamic 
structure regulated by the ovarian hormones, progesterone and estradiol. Human 
endometrium undergoes precise defined morphological changes with the aim of 
creating a suitable environment in the right window of time (from day 21 to day 24 of 
menstrual cycle) to receive the embryo. The cyclic control between gonadotrophins 
and ovarian steroids, is the key for a receptive endometrium and subsequently for a 
successful implantation.  
 
1.1  The menstrual cycle 
Every month, during reproductive lifespan, the women’s body undergoes a 
series of changes that leads to ovulation and prepares the uterus to receive the 
fertilized oocyte. When conception does not occur, the superficial endometrial layer 
starts to shed and the menstrual cycle is reinitiated. Menstrual cycle length is highly 
variable, ranging from 25 to 34 days in young women and also presents lifelong 
variations from menarche to menopause (3).  
The human menstrual cycle is characterized by a highly coordinated interplay 
between ovarian, pituitary and hypothalamic hormones, which are regulated by positive 
and negative feedback mechanisms. Before puberty, the hypothalamus is extremely 
sensitive to the suppressing effect of the very low levels of circulating estrogen. 
However, as puberty approaches, the hypothalamus becomes less sensitive resulting 
in the derepression of the gonadostat and a subsequent increasing secretion of 
gonadotrophins (4). From the time of puberty onward, the hypothalamic neurones, 
under the control of diverse neurotransmitters, secrete gonadotrophin-releasing 
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hormone (GnRH) in a pulsatile manner, which stimulates the production and secretion 
of follicule stimulating hormone (FSH) and luteinizing hormone (LH) by the pituitary 
gland. This stimulates the secretion of ovarian estrogen (estradiol) and progesterone, 
which in turn modulates the relative amounts of LH and FSH at the pituitary and 
regulates GnRH at the hypothalamus (5,6).This highly regulated chain of neuro-
endocrine phenomena is responsible for the ovary and uterus extensive remodelling 
throughout follicular/proliferative and luteal/secretory phases (Figure 1). 
 
1.1.1 Follicular or proliferative phase  
Until the 14th day of the menstrual cycle the growing ovarian follicles produce 
estrogen, which are responsible for the proliferation of the endometrium. The human 
ovary contains follicles at different stages of development, from the primordial to the 
preovulatory size. Although the initial recruitment of follicles is not dependent on 
gonadotropins, these hormones play a crucial role in their maturation and FSH, in 
particular, is responsible for the selection of the dominant follicle (7). During the 
process of maturation, follicles develop two layers of steroidogenic tissues constituted 
by granulosa cells surrounded by theca cells, which are responsible for the synthesis of 
ovarian steroidal hormones (8). In women, the action of these hormones on 
gonadotropin secretion can be investigated by administrating exogenous steroids or 
selective estrogen receptor modulators, by eliminating endogenous hormones through 
ovariectomy or by enhancing endogenous estrogen activity through ovarian stimulation 
(4). 
Although estradiol is the main secretory product of the follicle, progesterone is 
also produced in lower concentration by the ovaries during follicular phase (9). Both 
these ovarian steroids have an important role in the control of gonadotrophins 
secretion, in the context of the negative feedback mechanism (10), though the 
secretion of FSH does not only depend on estradiol and progesterone (11). Apart from 
the steroids, the ovaries also produce non-steroidal substances, such as inhibins (10). 
The major form of inhibin secreted during follicular phase is inhibin B. Its serum levels 
rise sharply from early follicular phase and declines thereafter until midcycle, while 
during luteal phase the concentration is low (10,12). 
In the follicular-luteal transition, there is a characteristic LH/FSH surge, due to 
the activation of a positive feedback mechanism via the secretion of high amounts of 
estradiol by the ovulatory follicle. This steroid sensitizes the pituitary to the 
hypothalamic GnRH (13), which together with the increasing concentration of 
progesterone and the reduced bioactivity of gonatrophin surge-attenuating factor 
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(GnSAF) is responsible for the modulation of the surge (14,15). The gonadotrophin 
surge is the physiological trigger to initiate a cascade of proteolytic events that control 
ovulation. Via its receptor, LH activates adenylyl cyclase and stimulates the protein 
kinase A (PKA) pathway, induces the rapid and transient expression of specific genes 
critical for ovulation in granulosa cells of preovulatory follicles (16). LH surge selectively 
induces the biosynthesis of cyclooxygenase-2 (COX-2) in granulosa cells, which in turn 
produces a rapid rise in follicular fluid prostaglandin E2 (PGE2) (17). The synthesis of 
biologically active prostaglandins by follicular cells seems to be an important factor for 
follicular rupture (18). However, their mechanism of action still remains to be elucidated 
(17). 
 
1.1.2 Luteal or secretory phase 
During the secretory phase, progesterone inhibits endometrial growth and the 
endometrium undergoes morphological and biochemical changes through a process 
called decidualization. This reaction is characterized by modification of uterine glands, 
influx of specialized natural killer cells, vascular remodelling and transformation of 
endometrial stromal fibroblasts into decidual cells.  
In the ovary, besides the activation of the machinery that leads to ovulation, the 
LH surge is also responsible for promoting the differentiation of somatic cells into luteal 
cells (19). The primary function of the corpus luteum is the secretion of progesterone, 
although it still retains the ability to produce some estradiol (20). These steroids control 
gonadotrophin secretion during luteal phase by a negative feedback mechanism. In 
contrast to inhibin B, inhibin A concentration is low in the follicular phase but increases 
to its maximal during the midluteal phase (21). Inhibin A has been shown to mediate 
negatively the FSH secretion (22), becoming one of the important components of the 
negative feedback control of gonadotrophin during this phase.  
During the passage from the luteal to the next follicular phase, an increase in 
serum FSH concentration occurs typically 2-3 days before the onset of the menstrual 
period (23). This intercycle rise of FSH is the result of the significant decline in estradiol 
and progesterone as well as inhibin A concentrations toward the end of the luteal 
phase and is responsible for the selection of the dominant follicle of the next cycle (10).  
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1.2  Endometrial remodelling  
Cyclical growth and decline of the endometrium is universal in non-pregnant 
mammals, but external loss of blood is only seen in primates and in very few other 
species (24). The process of menstruation occurs after progesterone withdrawal at the 
end of each menstrual cycle and is characterized by the loss of most of the stratum 
functionalis  accompanied by bleeding (25). Menstruation has many of the features of 
an inflammatory process. Progesterone has anti-inflammatory properties, and its rapid 
declining levels (along with estradiol) in the late secretory phase initiates a sequence of 
interdependent events of an inflammatory nature. Progesterone withdrawal induces the 
release of NF-κB from IκB leading to inflammatory gene expression, resulting in an 
influx of inflammatory cells. Interactions between these and decidualized stromal cells 
mediate the release of a wide variety of pro-inflammatory mediators including 
chemokines, cytokines and prostaglandins (26).	   The resultant leukocyte recruitment 
mediates the activation of matrix metalloproteinases (MMP), which is a prerequisite for 
tissue degradation at menstruation (26,27).  
Although it was initially thought that the endometrial repair was a subsequent 
process of menses, recent studies have suggested that shedding and repair occur 
simultaneously in adjacent areas during menses (28). This process of regeneration 
Figure 1. The human menstrual cycle. Coordination between gonadotropins (A) and ovarian hormones (B) is 
essential to regulate cyclic endometrial modifications (C). Adapted from (24). 
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shares common features with events of classic tissue injury and repair. Wound healing 
is a dynamic interactive process involving soluble mediators, blood cells, extracellular 
matrix and parenchymal cells. Similar to endometrial repair, it involves temporally 
overlapping phases of inflammation, tissue formation, remodelling and angiogenesis 
(1,25). The inflammatory process that is the basis of menstruation is also the initial 
point for the repair process. The occurrence of the apoptotic process is crucial for the 
resolution of inflammation, in particular by limiting the presence of inflammatory cells 
(1).  
The first stage of endometrial regeneration is the re-epithelialization, after which 
occurs the rapid renewal of endometrial glands, stroma and vasculature (29). During 
this proliferative stage, estrogen is the dominant hormone. As the levels of this 
hormone rise, estrogen receptors (ER) and progesterone receptors (PR) are induced in 
the epithelium and stroma and there is extensive proliferation of glandular epithelial 
cells in the functional layer (29). Angiogenesis occurs simultaneously to allow immune 
cell surveillance, oxygen supply to the new tissue and dispose waste (1,30). 
Angiogenesis is important during menstruation for repair of the vascular bed, during the 
rapid endometrial growth of the proliferative phase and during the secretory stage 
when spiral arterioles show significant growth and coiling (30). Numerous angiogenic 
factors have been identified in the human endometrium at the time of endometrial 
repair, though the vascular endothelial growth factor (VEGF) family genes is thought to 
be the most important (31). MMPs also play a key role in angiogenesis by degrading 
the extracellular matrix and permitting the migration and tube formation of endothelial 
cells (31).  
After regeneration, the endometrium undergoes secretory changes mediated by 
the increasing levels of progesterone. The implantation window coincides with the 
circulating peak of progesterone levels and depends on endometrium modifications, 
which occur as a result of the prior exposure to estrogen following increased levels of 
progesterone. The key endometrial events associated with the implantation window are 
the increased expression of chemokines and cytokines, the onset of decidualization 
and the presence of increased numbers of leukocytes including uterine natural killer 
(uNK) cells (32).  
 
1.2.1 Decidualization 
In the mid secretory phase of the cycle, the elongated, fibroblast-like stromal 
cells of the proliferative tissue begin to differentiate into larger, round, secretory and 
epithelioid-like decidual cells. Decidualized stromal cells (DSC) are also characterized 
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by rounding of the nucleus, expansion of the rough endoplasmatic reticulum and Golgi 
complex, and cytoplasmatic accumulation of glycogen and lipid droplets (33). 
Characteristic secretory products include prolactin (PRL) and insulin-like growth factor 
binding protein-1 (IGFBP1). Upon decidualization, these cells produce extracellular 
matrix (ECM) proteins such as type IV-collagen, laminin, decorin, fibronectin and 
heparan sulphate proteoglycans (34).   
Decidualization of the endometrium occurs only in species in which placentation 
involves breaching of the luminal epithelium by the trophoblast (35). It has been implied 
that the decidual process is necessary to protect the integrity of the mother against 
inflammatory signals and oxidative stress (36). 
In contrast to many species, human decidualization occurs independently of the 
presence of an implanting blastocyst and it affects all compartments, including 
junctional zone myocytes, spiral arteries, local immune cells, and the endometrial, 
epithelial and stromal compartments (33). It is a progressive process, initiated around 
the terminal spiral arteries of the superficial endometrial layer, which is also present in 
pregnancy and ultimately involves the entire endometrium (35).  
Microarray analysis has been used to elucidate the extension and magnitude of 
the molecular mechanisms underlying the process of decidualization and potential 
paracrine interactions between DSCs and other cell types in the endometrium during 
normal cell cycles and in early pregnancy. On the basis of these studies, 
decidualization has been described as a process of sequential reprogramming of 
functionally related families of genes involved in cell cycle regulation, ECM 
organization, cell adhesion, cytoskeletal organization, angiogenesis, immune 
modulation of implantation, steroid hormone action and metabolism, stress response 
and apoptosis modulation (33,37,38). 
Although the majority of original and review papers associate the initiation of 
the decidual process with the production of progesterone by the ovarian luteal cells, 
there are evidences that other physiologic effectors play a role in decidualization (39). 
In vivo, decidualization occurs about 10 days after the postovulatory increase of 
progesterone levels (40) and in vitro it takes 8 to 10 days for cells to decidualize under 
the stimulation of progesterone alone or in combination with estradiol (41). The initial 
and obligatory event that initiates the decidual process is the activation of the cyclic 
adenosine monophosphate (cAMP) pathway (33). cAMP is an ubiquitous second 
messenger molecule that is generated from adenosine triphosphate by adenylate 
cyclase. This enzyme is activated upon binding of a ligand to members of a family of 
G-protein-coupled receptors (GPCRs). These receptors mediate most of our 
physiological responses to hormones and neurotransmitters (42). Agonists activate 
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heterotrimeric (αβγ) G proteins by catalysing the replacement of GDP by GTP to the α-
subunit resulting in the dissociation of α-GTP from βγ subunits (43). Then, α-GTP 
carries the signal to effectors, resulting in hormonal stimulation or inhibition of adenylyl 
cyclase by αs or αi respectively (43). This second messenger causes the activation of 
PKA, a cytoplasmic enzyme composed by two regulatory and two catalytic subunits 
(44). Upon binding of two cAMP molecules to each regulatory subunit, the latter 
undergo a conformational change, which results in the release and activation of the 
catalytic subunits. These may phosphorylate target molecules in the cytoplasm or 
diffuse into the nucleus modulating, in that way, the activity of transcription factors (45).  
After ovulation, the endometrium is increasingly exposed to a variety of 
endocrine factors such as relaxin, prostaglandin E2 and gonadotropins, that are 
capable of stimulating cAMP production in stromal cells (39) by binding to GPCR 
coupled to the stimulatory Gsα protein (36). In fact, cAMP levels are higher in the 
secretory phase compared to the proliferative phase and it has been shown that 
treatment with a cAMP analog triggers the expression of the decidual markers, PRL 
and IGFBP1 (33). However, the decidual phenotype is not maintained in response to 
cAMP pathway alone. The inductive effect of cAMP on PRL production, by in vitro 
endometrial cells, was enhanced by medroxyprogesterone acetate (MPA), a 
metabolically stable progestin (39). Thus, cAMP signalling, via activation of the PKA 
pathway, sensitizes human endometrial stromal cells to progesterone (36). The 
mechanism by which cAMP potentiates PR activity remains a matter of debate, but it is 
thought to involve disruption of the interaction between the receptor and the 
corepressors NCoR and SMRT and to increase cooperation between coactivators such 
as SRC-1 and CBP (46). Besides this, it is also known that sustained elevated cAMP 
levels in human endometrial stromal cells induce the expression, or trigger the 
activation, of several downstream transcription factors, including forkhead box protein 
O1 (FOXO1), CCAAT/ enhancer-binding protein b (C/EBPb) and signal transducers 
and activators of transcription 5 (STAT5) (47).	   These decidua-specific transcription 
factors interact with PR, modulating the transcriptional competence of this nuclear 
receptor (48–50). Thus, decidualization requires a myriad of signalling pathways, 
transcription factors and cross talks to coordinate this temporary reprogramming of 
endometrial stroma (36).  
At the time of implantation, decidua is responsible for sensoring embryo quality 
(51). Cyclic decidualization coupled to menstruation emerged as a strategy for early 
detection and active rejection of developmentally abnormal embryos that have 
breached the luminal epithelium. Low quality embryos elicit an endoplasmic stress 
response in human decidual cells compromising secretion of decidual factors, including 
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PRL and IGFBP1, essential for placental formation and fetal development (51). On the 
other hand, impaired cyclic decidualization of the endometrium facilitates implantation 
yet predisposes to subsequent pregnancy failure by disabling natural embryo selection 
and disrupting the maternal responses to embryonic signals (52). In fact, impaired 
decidualizing process is increasingly linked to a variety of pregnancy disorders, 
including infertility, recurrent miscarriages, utero-placental disorders, endometriosis, 
and endometrial cancer.  
Decidua acquires the unique ability to control trophoblast invasion, to resist 
inflammatory and oxidative insults and to assuage maternal immune responses (Figure 
2). The former is regulated through the creation of a dense cellular matrix, which 
promotes the trophoblast attachment and, at the same time, limits the aggressive 
invasion by the fetal tissue.  This process relies on an intricate communication between 
trophoblast and maternal decidua, which requires proteolytic enzymes, such as MMPs 
and plasmin and their corresponding inhibitors (33,53).  
 
 
Figure 2.  Decidual transformation of human endometrial stromal cells in vitro. Undifferentiated primary cells display a 
fibroblastic spindle-shaped morphology (left panel). After treatment with cAMP and progesterone cells acquire a 
decidualized epithelioid phenotype (right panel). This transformation in vivo underpins the acquisition of specialized 
functions. Impaired decidualizing process is increasingly linked to a variety of pregnancy disorders. (47) 
 
In early pregnancy, maternal circulation to the placenta is extremely slow due to 
the plugging of spiral arteries by invading endovascular trophoblast. The human 
uteroplacental unit develops initially in a low-oxygen environment protecting the 
embryo against reactive oxygen species (ROS) (33,53). Unplugging of the arteries 
generates a burst of oxidative stress. Therefore, it is critical for the conceptus survival 
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to ensure the integrity of the feto-maternal interface. It is known that human 
endometrial stromal cells become extraordinarily resistant to oxidative stress-induced 
apoptosis upon decidualization (54) through the induction	   of various free radical 
scavengers, most notably superoxide dismutase 2, monoamine oxidases A and B, 
thioredoxin, glutaredoxin, and peroxiredoxin (47).	   
The human decidua also contains a high number of immune cells, such as 
macrophages, natural killer cells and regulatory T cells. This specific immune cells 
pattern represents a substantial entity, which exerts variable physiologic functions like 
maintaining immune tolerance toward implanted allogeneic embryo, surveillance 
against infections and neoplastic transformations, important functions related to 
placenta development (55). Deletion of these cells has deleterious effects on placental 
development, implantation, or decidual formation (56). On the other hand, upon 
decidualization, the differentiated stromal cells produce cytokines, chemokines and 
MMPs, that stimulate natural killer (NK) cells differentiation into uNK, monocytes 
recruitment and tissue remodelling (55). Therefore, a rigorous cross talk between 
decidual and immune cells is a requisite for pregnancy, though it is still a great 
challenge to understand the intricacy of fetal-maternal system behind a successful 
outcome.  
 
 
2 Endocannabinoid system 
Cannabis plant has been used for thousands of years as a source of useful 
fibre for textile manufacturing, a medicine and a recreational drug. The use of cannabis 
(or marijuana) as a psychoactive substance was introduced a long time ago in central 
Asia, spreading gradually to India, Minor Asia and Africa. It only reached Europe and 
America in the 19th century and now, it is one of the most consumed illicit drugs 
worldwide (57). The attractiveness of marijuana as a recreational drug is due to its 
ability to alter sensory perception and cause elation and euphoria (58). 
Cannabis sativa contains over 60 cannabinoids as well as over 400 other 
chemicals (59). It was a major breakthrough in the 1960s, when Gaoni and Mechoulam 
identified delta-9-tetrahydrocannabinol (THC) as the most important psychoactive 
cannabinoid (60). Initially, it was suggested that due to its strong hydrophobic nature, 
THC would elicit its effects non-specifically by perturbing lipids. However, the synthesis 
and biological studies of enantiomers of THC and its synthetic analogues revealed that 
its principal pharmacological actions were enantioselective, a telltale sign of drug-
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receptor interaction (58,61). Henceforth, the idea of a cannabinoid receptor and a 
whole endocannabinoid system was built and investigated. 
Recently it was described that THC, by competing with the endogenous 
cannabinoids, may cause changes in the endocannabinoid signalling cascade with 
possible consequences for the biological functions of the endocannabinoid system (62) 
comprised by cannabinoid receptors, their endogenous ligands (endocannabinoids), 
enzymes for their synthesis and degradation and transporter (Figure 3).  
 
Figure 3. Components of the endocannabinoid system. Endocannabinoids, anandamide (AEA; blue circles) and  2-
arachidonoylglycerol (2-AG; orange circles), are transported through cell membrane  via the putative endocannabinoid 
membrane transporter (EMT). AEA is catalysed by the N-acyltransferase (NAT) followed by NAPE-specific 
phospholipase D (NAPE-PLD). 2-AG synthesis occurs through diacylglycerol lipase (DAGL). Endocannabinoids  interact 
with cannabinoid receptors (CB). AEA is hydrolyzed by fatty acid amide hydrolase (FAAH) into ethanolamine (EtNH2) 
and arachidonic acid (AA). 2-AG is hydrolyzed through monoacylglycerol lipase (MAGL) or FAAH into glycerol and 
arachidonic acid (66).  	  
2.1 Receptors 
Initially, it was found that the treatment of neuroblastoma cells with THC 
inhibited adenylate cyclase activity and that this action was stereoselective (63). This 
evidence allied to radioligand binding assays (64) and cloning of cDNA encoding a G-
protein coupled receptor from rat cerebral cortex (65) were the starting point for the 
discovery of the first specific cannabinoid receptor (CB1). The existence of a second 
cannabinoid receptor, named CB2, was then identified. CB1 is the primary cannabinoid 
receptor in the central nervous system and is widely distributed throughout the brain 
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and at lower levels in peripheral tissues (immune system, vascular endothelium, 
intestine, liver, peripheral nerve synapses and reproductive system) (66). CB2 is 
expressed primarily by immune cells, including microglia (67). CB1 and CB2 receptors 
belong to the Class A (rhodopsin-like) of G-protein coupled receptors, which comprise 
seven transmembrane helices connected by three intracellular and three extracellular 
loops with a N-terminal extracellular domain and a C-terminal intracellular domain (68). 
Molecular modeling analysis based on the X-ray-crystal structure of similar receptors 
revealed the hypothesis that CB1 and CB2 present an opening between 
transmembane helices that allows ligand to pass from the lipid bilayer into the 
hydrophobic binding pocket (69,70). Pharmacological studies have shown that besides 
CB1 and CB2, endocannabinoids also interact directly with other molecular targets, 
including non-CB1, non-CB2 G-protein-coupled receptors and various ion channels. An 
orphan GPCR, GPR55, with the ability to interact with and be modulated by 
endogenous plant and synthetic cannabinoid ligands, was considered a novel 
cannabinoid receptor (71). GPR55 shares only 13.5% sequence homology with CB1 
and 14.4% with CB2.
 
 The levels of GPR55 mRNA expression are notably between 
three- and tenfold lower than those reported for the cannabinoid CB1
 
receptor (72). 
GPR55 might also be activated by the bioactive lipid L-α-lysophosphatidylinsoitol and 
related lipids, which apparently do not bind to CB1 or CB2 (72). In addition to the 
receptors above mentioned, endocannabinoids were also described to interact with the 
orphan G-protein coupled receptor GPR119, with trasient receptor potential (TRP) 
channels (also known as vanilloid receptors) and peroxisome proliferator-activated 
receptors (PPARs) (66,73). 
The discovery of the cannabinoid receptors was just the tip of the iceberg in the 
study of the endocannabinoid system. Today, the knowledge of this field of research 
encompasses the identification of endogenous ligands and their entire metabolism as 
well as the signalling pathways through which endocannabinoids exert their action.  
 
2.2. Endogenous cannabinoids and their metabolism 
Endocannabinoids are derivatives of integral components of cellular 
membranes and act as hydrophobic lipid messengers. These molecules have been 
described to be involved in basic biological processes, including cell choice between 
survival and death, immune response, neurotransmission, energy homeostasis and 
reproduction. These compounds exhibit “cannabimimetic activity”, that is, they act as 
“THC mimetics”.  
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The first endocannabinoid to be identified was arachidonoylethanolamide (AEA; 
anandamide) isolated from porcine brain (74), which was followed by the identification 
of 2-arachidonoylglycerol (2-AG). AEA and 2-AG are the best characterized members 
of the main families of eCBs, N-acylethanolamines (NAE) and monoacylglycerols 
(MAG), respectively (66). Although similar in structure and general function, these 
endocannabinoids exhibit large differences in terms of biochemical steps, receptor 
affinity, and breakdown pathways (75). Other endogenous ligands to cannabinoid 
receptors have been discovered: 2-arachidonoylglyceryl ether (noladin ether, 2-AGE), 
O-arachidonoylethanolamine (virodhamine), N-arachidonoyldopamine (NADA), N-
arachidonoylglycine (NAGly) and Cis-9,10-octadecanoamide (oleamide or ODA) (66) 
(Figure 4).  
 
Figure 4. Chemical structure of endocannabinoids. Structure of the two main endocannabinoids (anandamide and 2-
arachidonoylglycerol) and other endogenous cannabimimetic molecules that have thus far been identified (virodhamine, 
noladin ether, N-arachidonoyldopamine, N-arachidonoylglycine and oleamide). 
 
 
The AEA precursor is N-arachidonoyl-phosphatidylethanolamine (NAPE), which 
is originated from the transfer of arachidonic acid from phosphatidylcholine to the head 
group of phosphatidylethanolamine, catalyzed by N-acyltransferase (NAT) (66,75). 
This occurs through enhanced intracellular Ca
2+ concentrations, e.g. from cell 
depolarization or mobilization of intracellular Ca
2+ stores (66). NAPE is then cleaved by 
a phospholipase D (NAPE-PLD) releasing AEA and phosphatidic acid (76). Recent 
studies have reported the existence of at least three other alternative pathways for 
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AEA synthesis (Figure 5). NAPE can be converted into phospho-AEA by a 
phopholipase C (PLC) and then dephosphorylated by a phosphatase. LysoNAPE, 
synthesised by a specific phospholipase A2 (PLA2), is hydrolyzed to AEA by a lysoPLD. 
NAPE can also be deacylated by ABHD4 generating glycero-p-AEA that is cleaved to 
AEA by a phosphodiesterase (75,77). Once taken up by the cells AEA is primarily 
degraded by fatty acid amide hydrolase (FAAH) releasing arachidonic acid and 
ethanolamine (66). Besides FAAH, AEA can be hydrolyzed by N-acylethanolamine-
hydrolyzing acid amidase (NAAA) and oxygenated by COX-2, lipooxigenase 
isoenzymes (LOX), and by P-450 cytochrome (75). 
 
 
Figure 5. Metabolism of anandamide. AEA can be synthesized and degraded through multiple pathways. Transfer of 
arachidonic acid from 1-arachidonoyl-phosphatidylcholine (PC) to phosphatidylethanolamine (PE) is catalysed by NAT, 
thus generating the AEA precursor, N-arachidonoyl-phosphatidylethanolamine (NAPE). NAPE can be directly cleaved 
by NAPE-PLD or through alternative pathways until AEA is synthetized. The major route for AEA degradation is the 
hydrolysis to arachidonic acid (AA) and ethanolamine.  
 
 
After biosynthesis, anandamide is released to extracellular space to activate the 
cannabinoid receptors or act inside the cell in the TRVP1 or PPARs. Different 
hypothesis have been put forward to explain AEA transport, namely i) passive diffusion 
assisted by the formation of AEA-cholesterol complexes, ii) caveolae-related 
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endocytosis and iii) facilitated transport mediated by a selective and saturable 
transporter, the  “anandamide membrane transporter” (AMT) (77).  
Within the cell, AEA is either metabolized, which maintains the concentration 
gradient or is sequestred by lipid droplets (adiposomes) (78). FAAH is generally 
accepted as the key regulator for AEA gradient and consequent uptake. However there 
are experiments reporting AEA uptake in FAAH -/- mice, suggesting the existence of 
alternative AEA gradient regulators (78). An additional way of reducing the free 
intracellular AEA concentration is the binding to intracellular proteins. Fatty-acid-
binding proteins (FABP)-5 and -7, albumin, heat shock protein 70 and the FAAH-like 
anandamide transporter protein (FLAT) have been identified as AEA intracellular 
binding proteins (AIBPs) (78).  Although the majority of literature claims that AEA is 
synthesized and released exclusively “on demand”, the existence of AIBPs and storage 
into adiposomes suggest that this idea should be reconsidered (77,79).  
 
2.3 Signal transduction pathways 
G-protein-coupled receptors can adopt multiple conformations, leading to 
different signalling events. These different conformations can be caused by different 
ligands, which can behave as agonist, antagonist or inverse agonist in another 
receptors. Inhibition of adenylyl cyclase via Gi/o is the best characterized CB1
 
signalling 
pathway, as it results in reduced  cAMP-stimulated PKA activity (80). A CB1-mediated 
activation of PKA has been shown to promote Ca
2+ influx into neuroblastoma cells (81)  
and regulate K-type K+ channels in hippocampal neurons (82). Stimulation of 
cannabinoid receptors can also inhibit L-, N- and P/Q- type calcium channels (83). 
G-protein coupled receptors can regulate cell proliferation, cell differentiation, 
cell motility and cell death through activation of MAPK pathways, which are organized 
hierarchically leading to activation of ERK1/2 (also known as p42/p44 MAPK), c-Jun N-
terminal kinase (JNK), focal adhesion kinase (FAK), p38 MAPK or ERK5 proteins 
(66,83).  These multiple pathways mediated by CB1 stimulation depend on the cell 
type and stimulus (80). CB1 activation by THC, anandamide or synthetic cannabinoids 
can also induce the activation of protein kinase B (PKB, also known as Akt) with the 
involvement of phosphoinositide 3’-kinase (PI3K) (84) (Figure 6).  PKB plays a pivotal 
role in the regulation of basic cell functions such as energy metabolism and 
proliferation.  
Cannabinoids can also modulate the intracellular levels of ceramide, which is 
an ubiquitous sphingolipid second messenger with an important role in the control of 
cell fate (85). Activation of CB1
 
can produce two peaks of ceramide. Short-term 
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ceramide generation involves sphingomyelin (SM) hydrolysis via sphingomyelinase 
(SMase) activation through the adaptor protein FAN and acts on metabolic regulation. 
Long-term ceramide generation may occur via serine palmitoyltransferase (SPT) 
induction and enhanced ceramide synthesis de novo, being linked to the induction of 
apoptosis (85).  
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1 Involvement of AEA in cell survival/death decision 
The precise mechanisms through which cannabinoids induce apoptosis are still 
unclear, specially, because several mechanisms appear to be involved. Differences in 
cell type, receptor expression and/or the available concentrations of agonists result in 
activation of different signalling pathways. In fact, the proapoptotic activity of AEA in 
different cellular models has been shown to occur through the activation of different 
receptors (76).  
In rat cortical astrocytes and human astrocytoma cells, proapoptotic signalling 
induced by AEA is mediated by CB1 receptor leading to activation of JNK and p38 
MAPK (86). In the same cells, the activation of CB1 also leads to sphingomyelin 
breakdown through the adaptor protein FAN and independent of Gi/o proteins, 
suggesting that a threshold might exist above which endocannabinoid-induced JNK 
and p38 MAPK activation would lead to cell death (86,87). It may be speculated that 
AEA binding to CB1 receptors modulates the balance among ERK, JNK and p38 
MAPK, thus regulating the cell choice between proliferation and death (76). In rat 
Figure 6. Cannabinoid receptor-coupled signalling pathways. Cannabinoids exert their effects through the stimulation of 
Gi/0 protein-coupled receptor signalling inhibition of adenylyl cyclase (AC). CB1 receptor mediates ceramide accumulation 
and modulates ion channels. Activation of the CB1 receptor can also stimulate various intracellular kinases, such as 
extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), focal adhesion kinase (FAK), and p38 MAPK 
(p38). All these events participate in the control of cell function by cannabinoids. (67) 
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decidual cells, AEA induces cell death through CB1 (88) involving ceramide and p38 
MAPK pathway (66). In addition it was also demonstrated that anandamide induced 
cell death in PC12 cells through activation of p38 MAPK and JNK proteins independent 
of CB1 or vanilloid receptors (89). Increasing data indicates that more sophisticated 
mechanisms should be involved in the regulation of cell death by cannabinoids. 
Potentially, AEA may exert its effects by direct inhibition of T-type calcium channels 
(90). Anandamide-induced cell death might also be mediated through membrane lipid 
rafts independent of cannabinoid or vanilloid receptors (89). Furthermore, recent 
findings enhance COX-2 contribution to cannabinoid-induced apoptosis. Treatment of 
human neuroglioma cells with the stable analogue of AEA (methanandamide) resulted 
in the induction of apoptosis via lipid raft-mediated events. The signal transduction 
pathway involved an increase of ceramide levels, expression of COX-2 and 
subsequent prostaglandin E2 synthesis involving p38 MAPK and ERK activation (91). 
It has also been shown that cannabinoids are able to modulate, once more 
through CB1 receptors, the phosphatidylinositol 3-kinase/ protein kinase B (PI3K/PKB) 
pathway, which serves as a pivotal anti-apoptotic signal (92). This finding is of 
particular interest, because it points towards a protective role of cannabinoid receptors 
against programmed cell death (76).  In human neuroblastoma CHP100 and lymphoma 
U937 cells, anandamide induced apoptotic bodies formation and DNA fragmentation, 
hallmark features of programmed cell death, via vanilloid receptors (93). In the same 
study, it was suggested that activation of cannabinoid receptors may also have a 
protective role against apoptosis. Thus, AEA might exert a pro-apoptotic activity by 
binding to vanilloid receptors and an anti-apoptotic action by binding to cannabinoid 
receptors (76). Protection against apoptosis following CB1 activation has been 
reported in several cellular models (76).  
 
3 Endocannabinoid system in female fertility 
Over the past half century, fertility rates have declined at an unprecedented 
speed, so that infertility has become an urgent public health issue specially in 
developed countries. Although, a great effort has been made to overcome infertility 
through assisted reproduction technologies (ART), it is still a major concern to 
understand the molecular mechanisms behind a successful pregnancy.  
Reproductive functions are under a fine regulation exerted at multiple levels 
along the hypothalamic-pituitary-gonadal (HPG) axis. The formation of high quality 
gametes, followed by a successful pregnancy event, is the result of deep cell-to-cell 
communications (94). Numerous signalling molecules have been indentified as 
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potential modulators of reproductive activity. The endocannabinoid system (ECS) is 
one of these novel players implicated in the process of implantation and maintenance 
of pregnancy (95). Endocannabinoid signalling pathways are involved in fertilization, 
oviductal transport, implantation, embryo development and maintenance of early 
pregnancy (Table 1). AEA is now thought to be the key link between the developing 
embryo and the endometrium, ensuring synchronous development of the 
preimplantation embryo and the endometrium, thereby facilitating the embryo 
implantation during the ‘implantation window’ (96).  
 
Table 1. Overview of the most important biological activities of endocannabinoids in the female reproductive organs.  
Ovary - oocyte maturation 
- folliculogenesis 
Oviduct - embryo transport 
Endometrium 
- embryo implantation 
- endometrial plasticity 
- endometrial cell motility 
- cytoskeleton rearrangement 
- endometrial cell proliferation 
- endometrial decidualization 
 
 
3.1 Endocannabinoid levels during menstrual cycle 
Endocannabinoids play an important role in folliculogenesis, ovulation, oocyte 
maturation and endometrium receptivity (97). Plasma anandamide levels fluctuate 
through the menstrual cycle with an increase at the follicular phase (1.45 ± 0.81 nM) 
compared with the luteal phase (0.77 ± 0.30 nM) (97). Higher levels occurring at the 
time of ovulation followed by a substantial decrease during the early to mid-secretory 
phase, when implantation occurs, are required to ensure a successful pregnancy (98).  
Studies measuring FAAH expression in the peripheral lymphocyte during the 
secretory phase of the menstrual cycle around the time of implantation suggest that 
increased lymphocytic FAAH expression could be a controlling factor in plasma 
anandamide levels at this time (99). The highest FAAH activity and the lowest AEA 
concentration are registered on Day 21, a time point corresponding to the putative 
window of uterine receptivity for implantation (100). Besides, low FAAH and high AEA 
levels in blood were associated with spontaneous miscarriage (99). In addition, women 
undergoing successful ART show low levels of AEA at the time of implantation, 
compared with women who fail to become pregnant (98). The differential expression of 
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FAAH and NAPE-PLD in the endometrium, suggest a key role for these enzymes in 
controlling local AEA concentrations during the menstrual cycle (101).  
The precise mechanisms by which endocannabinoids influence reproduction 
are uncertain, although the involvement of COX-2 may be one of them. Maintenance of 
appropriate AEA levels may be partly dependent upon oxidation by COX-2, which 
catalyzes the conversion of AEA to prostamides (prostaglandin-ethanolamides) (96).  
In fact, studies in mice showed that COX-2 might be essential for processes such as 
ovulation, fertilization, implantation and decidualization (102).  
In addition to the direct effects proposed for endocannabinoids on reproduction, 
the ECS also interacts with sex steroid hormones and cytokines to regulate 
reproduction indirectly (96).  
Estrogen response elements have been identified in FAAH gene sequence. 
Estrogen receptors down-regulate FAAH gene transcription, independent of its ligand 
and possibly through interference with the activity of positively regulating nuclear 
proteins such as AP-1, SP1, or other transcription factors (103). The overall 
relationship between estrogen and endocannabinoids can be described as 
“bidirectional” (94). In one direction, endocannabinoid activity reduces the release of 
estrogens via the central down-regulation of LH and GnRH (94,104). In contrast, 
decreasing FAAH activity and modulating CB expression, estrogen up-regulates AEA 
production (94). 
Evidences show that endocannabinoids might also regulate negatively the 
release of progesterone by controlling LH release (94).  On the other hand, 
progesterone up-regulates FAAH activity and thereby decreases AEA levels (96). In 
addition, cytokines such as LIF, Th1/Th2 and leptin that are essential for implantation, 
interact with the ECS, which ultimately have impact on fertility (96).	   Thus, for a 
successful implantation and maintenance of early pregnancy it is required a tight 
control of the hormone-cytokine network.  
 
3.2 From the ovary to the uterus 
Human oocytes express CB1 and CB2 receptors, whose localization changes 
with the different oocyte maturation stages. Immunostaining of normal human ovaries 
indicates that the ECS is present and widely expressed in the ovarian medulla and 
cortex, with more pronounced CB2 than CB1 immunoreactivity in the granulosa cells of 
primordial, primary, secondary, tertiary follicles, corpus luteum and corpus albicans 
(105).  On the other hand, AEA metabolizing enzymes, FAAH and NAPE-PLD are only 
expressed in the granulosa and theca cells of secondary and tertiary follicles, in the 
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corpus luteum and in the corpus albicans (105). Thus, the ovary is able to produce 
AEA, which may play a role in folliculogenesis, preovulatory follicle maturation, oocyte 
maturity and ovulation. According to these results, the higher plasma AEA levels are 
registered at the time of ovulation, suggesting that the ECS may be required for the 
process of ovulation.  
Embryo retention in the fallopian tube is one of the causes of ectopic pregnancy 
and consequent miscarriage. It has been shown that CB1 receptor regulates normal 
oviductal transport of embryos in mouse oviduct. In fact, genetic or pharmacologic 
silencing of cannabinoid receptor CB1 causes retention of a large number of embryos 
in the mouse oviduct, eventually leading to pregnancy failure (106). Also, wild-type 
females exposed to a stable AEA analogue (methanandamide) or natural THC had the 
same phenotype as Faah-/- mice with oviductal transport defects, which was rescued 
by CB1 antagonist treatment (106,107). A critical balance between AEA synthesis, by 
NAPE-PLD, and its degradation, by FAAH, both in mouse embryos and oviduct, 
creates a locally appropriate “anandamide tone” (107).  
In the uterus, the endometrium represents a significant source of endogenous 
cannabinoids, and AEA levels are higher than in other reproductive tissues (108). 
Throughout the menstrual cycle, FAAH and NAPE-PLD expression in stromal and 
glandular compartments is responsible for the modulation of AEA concentrations as 
referred above.  
Initially it was described that CB1 immunoreactivity is not modulated throughout 
the menstrual cycle (101). However, a study reported a dramatic increase in CB1 
mRNA and protein in normal endometrial samples in the secretory phase likely due to 
progesterone modulation (109).  On the other hand, CB2 expression levels are minimal 
at the end of the menstrual cycle and reach a peak during the late proliferative phase 
(101).  
Recent data support the idea that the ECS plays an important role in the control 
of endometrial plasticity by regulating endometrial cell motility (108). For instance, 
methanandamide stimulates endometrial stromal cell migratory phenotype by inducing 
rapid changes in the cytoskeleton architecture and increasing electrical signal 
generated by K+ channels (108). Cannabinoids may also interfere with the proliferation 
of endometrial cells. Treatment with the agonist WIN 55212-2 has an anti- proliferative 
effect on endometriotic and endometrial stromal cells mediated by a mechanism 
involving reduction of reactive oxygen species production and inactivation of the Akt 
pathway (110). Thus, the ECS may represent a promising approach in the treatment of 
deep infiltrating endometriosis. 
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3.3 Endocannabinoids at implantation and maternal-fetal interface 
Attachment of the embryo to the luminal epithelium of the maternal uterus is a 
crucial step in mammalian reproduction. Synchronous development of the 
preimplantation embryo to the blastocyst stage and the uterus to a receptive stage is 
essential to the processes of implantation (Figure 7). On the maternal side it is critical 
the process of decidualization. It has been proposed that decidual cells are probably 
the main controllers of uterine endocannabinoid levels during rat pregnancy (111). The 
differentiation of stromal cells and apoptosis of the receptive decidua are crucial 
processes for the controlled invasion of trophoblasts in normal pregnancy. In rat, it was 
suggested that anandamide may play an important role in regulating apoptosis through 
CB1 and thereby modulate decidual stability and regression during pregnancy(88). 
This mechanism is triggered by ceramide synthesis de novo and p38 phosphorylation, 
followed by mitochondrial stress and ROS production (112). In human endometrial 
stromal cells, activation of CB1 by R(+)-WIN 55,212-2 mesylate inhibits decidualization 
process and promotes apoptosis of decidual cells by a cAMP-dependent mechanism 
(113). 
Apart from the importance of the ECS in the modulation of decidualization, it 
has also been suggested that low levels of anandamide is important for implantation 
competence (114). Actually, the levels of uterine anandamide and blastocyst CB1 
expression are regulated to synchronize preimplantation events and uterine receptivity 
for implantation in mice (114). Thus, encocannabinoid signalling is at least one of the 
pathways that determines the fate of implantation and ultimately successful pregnancy. 
However, the importance of the ECS does not end here. Evidence has been provided 
that it is also involved in early pregnancy events as well as the labor onset.  
Placenta serves as an interface for the exchange of nutrients, gases, and 
wastes between the maternal and fetal compartments. Moreover, placenta can secrete 
many hormones and growth factors conducive to the success of pregnancy 
establishment and maintenance (94). It has been further demonstrated that CB1, 
FAAH, and NAPE-PLD are expressed in human placenta. The levels of FAAH in the 
human placenta increase towards the end of the first trimester of pregnancy, before 
declining by the early second trimester (115). Furthermore, findings suggest that the 
placenta may form a barrier preventing maternal-fetal transfer of anandamide and/or 
modulate local levels of this endocannabinoid by regulating FAAH expression 
throughout gestation (115).  
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Figure 7. Fetomaternal interface and potential adverse effects of deregulated endocannabinoid levels. Based on 
rodents and human studies, endocannabinoids may be critically involved in decidualization, implantation, and 
trophoblast differentiation and invasion. Aberrant endocannabinoid levels (shown in yellow boxes) is reflected in 
compromised reprogramming of the endometrial stromal cells, implantation and placentation manifesting in ectopic 
pregnancy, intrauterine growth restriction, preeclampsia, miscarriage, and spontaneous abortion. Adapted from (116). 
 
 
A recent study demonstrates that aberrant endocannabinoid signalling plays an 
important role in the pathophysiology of preeclampsia. The placental expression of 
NAPE-PLD is significantly higher in preeclamptic pregnancies, while FAAH exhibits an 
opposite result (117). 
Additionally, during labour, AEA levels were 3.5-fold higher than non-labouring 
term levels (2.5 versus 0.7 nM), suggesting that increased levels of AEA are required 
to sustain normal labour, whereas successful implantation and pregnancy progression 
require low levels of this endocannabinoid (118).   
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4 Aims 
 
Increasingly, the endocannabinoid system has been implied in a wide array of 
physiological and pathological processes. In female reproduction, recent evidence 
proposed that anandamide levels must be tightly modulated to assure a successful 
pregnancy. On the other hand, endometrium proliferation and differentiation are crucial 
processes for the creation of a favourable environment for receiving the blastocyst 
(implantation) and permitting embryo-fetal development. Over the last few years, a 
great effort has been made to understand the intricacies between the ECS and female 
fertility. Studies show that endocannabinoids might be related with endometrial stromal 
cells proliferation and also affect the process of decidualization, which could ultimately 
interfere with the development of a possible pregnancy. However, this relationship is 
still unclear and the mechanisms through which endocannabinoids exert their action on 
human endometrial stromal cells are unknown. Therefore, the aim of this work is to 
unveil the effect of anandamide in the stromal lining and to lift the tip of the veil to 
understand the underlying regulatory mechanism that might be behind this effect.  
Since most studies that examine the role of endocannabinoids in the 
reproductive system have been carried out in rodents, it is still difficult to determine the 
effect of endocannabinoids in human female fertility. Besides, due to ethical reasons it 
is also difficult to use first trimester maternal tissues. In this study was used, for the first 
time, a telomerase-immortalized endometrial stromal cell line, St-T1b cell line. This cell 
line expresses the appropriate phenotypic endometrial stromal cell markers and the 
decidual response closely mimics that of primary cultures. Thus, we intend to 
investigate the effect of AEA either in non-differentiated as well as in the decidua 
formation. It will also be explored the optimum conditions for in vitro differentiation of 
human endometrial stromal cells. Additionally, the effect of anandamide will be 
evaluated in non-differentiated term decidua fibroblast cells, which has been described 
to resemble endometrial stromal cells. 
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II Methods 	  	  
1 Materials 
Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12), fetal 
bovine serum (FBS), antibiotic–antimycotic (10,000 units/ml penicillin G sodium, 
10,000 mg/ml streptomycin sulphate and 25 mg/ml amphotericin B) were supplied by 
Gibco Invitrogen Co. (Paisley, Scotland, UK). Insulin, 17-β-estradiol, 8-Br-cAMP, 
collagenase, 3-(4,5-dimethylthiazol-2-yl)-2,5-difenyltetrazolium (MTT), Hoechst 33258, 
propidium iodide (PI), Triton X-100, Dnase-free Rnase A, staurosporine (STS), 
charcoal, isopropyl alcohol, chloroform, fluoroshield, Sigma Fast Red™ tablets and 
hematoxylin were from Sigma-Aldrich Co. (Saint Louis, MO, USA). AEA and AM 251 
were supplied by Tocris Bioscience (Minneapolis, MN, USA). CytoTox 96 
nonradioactive cytotoxicity assay kit was from Promega (Fitchburg, WI,USA). 3H-
thymidine was from Amersham Biosciences Corp. (Piscataway, NJ, USA). DPX and 
Aquamount medium was from VWR (Radnor, PA, USA).  Giemsa was from Merck 
(Whitehouse Station, NJ, USA). Caspase-Glo® 3/7 luminometric assay was from 
Promega Corporation (Madison, WI, USA). VECTASTAIN ABC Kit was from Vector 
Labs (Burlingame, CA, USA). TRIsure was from Bioline (London, UK). KAPA SYBR 
FAST qPCR Kit was from Kapa Biosystems (Milmington, MA, USA). iScript cDNA 
Synthesis Kit was from BioRad (Hercules, CA, USA). Chemiluminescence detection kit 
was from Super Signal West Pico (Pierce, Rockford, USA). X-ray films were from 
Kodak XAR (Rochester, NY). 
 
2 St-T1b cell line culture 
The human endometrial stromal cell line St-T1b was kindly supplied by Dr. 
Birgit Gellersen from Endokrinologikum Hamburg, Hamburg, Germany. This cell line 
was obtained from uterine biopsy samples at the time of hysterectomy for benign 
gynaecological disorders and immortalized with human telomerase reverse 
transcriptase (hTERT) (119). These cells were maintained at 37ºC with 5% CO2 in 
DMEM/F-12 medium supplemented with 10% charcoal-stripped FBS, 1 nM 17-β-
estradiol (E2), 1 µg/ml Insulin and 2% penicillin-streptomycin. FBS was previously 
inactivated for 1h at 56ºC and then treated with activated charcoal for 24 h. For each 
experiment cells were firstly incubated for 72 h in completed medium and then treated 
with only 1% FBS.  
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3 Decidualization of St-T1b cell line 
St-T1b cells differentiation was performed in minimal medium 1 (MM1), which 
corresponds to DMEM/F-12 medium supplemented with 2% charcoal-stripped FBS and 
2% penicillin/streptomycin. Decidualization was induced through three different 
treatments: 1) 0.5 mM 8-Br-cAMP and 1 µM MPA; 2) 20 nM forskolin (Fsk) and 1 µM 
MPA; 3) 10 µM PGE2, 1 µM MPA and 10nM E2. 
 
4 Isolation and culture of term decidua fibroblast cells 
The protocol for the isolation of cells from term decidua was implemented 
based on Richards et al, 1995 (120) with some additional steps. Term human 
placentas from caesarean section or vaginal delivery following uncomplicated 
pregnancies were obtained from Centro Materno-Infantil do Norte, Porto. All the 
procedures using term placentas were performed according to the Ethical committee of 
Centro Materno-Infantil do Norte. The decidua basalis was scraped from the chorionic 
membrane, dissected into small pieces and enzymatically digested in PBS with 
collagenase (1 mg/ml) for 1 h at 37 ºC with gentle shaking. The suspension was then 
centrifuged at 260 x g for 6 min and the pellet was ressuspended and incubated with 
ammonium chloride solution (0.8 g tissue culture grade NHCl, 0.084 g NaHCO and 
0.037 g EDTA in 100 ml H20) to lyse red blood cells during 5 min at 37 ºC. The 
resulting suspension was filtered through a 60 µm nylon mesh followed by a 40 µm 
nylon mesh and centrifuged at 260 x g for 10 min. The isolated cells were cultured in 
complete DMEM/F-12 medium. After 24 h, the non-adherent cells were removed and 
the cells were grown to confluence and sub-cultured. By subpassage 3, essentially all 
the cells were proliferating fibroblasts. Cells from 3 to 10 subpassages were used in 
these studies. To determine the ideal initial cellular density three different densities 
were tested (2 x 103; 2.5 x 103 and 5 x 103 cells/ per well) in 96-well plate.  
 
5 Cell viability and cell proliferation 
Cell viability was ascertained by the tetrazolium salt MTT assay and by 
measuring the LDH release. St-T1b cells and primary cells were cultured at a density 
of 2.5 x 103 cells/ well in 96-well plates and incubated with different concentrations of 
anandamide (0.01 µM – 50 µM) during 24, 48 and 72 h. After incubation, MTT (0.5 
mg/ml) was added to each well and the plate was incubated for 2 h 30 min at 37ºC. 
The formazan was dissolved by the addition of DMSO: isopropanol mixture (3:1) and 
quantified spectrophometrically (540 nm). To verify the role of cannabinoid receptor, 
the antagonist of CB1, AM 251, was added 30 min prior to anandamide.  
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Lactate dehydrogenase is a stable cytosolic enzyme that is released from cells after 
cell lysis or membrane damage and thus it is extensively used as a marker for 
cytotoxicity. LDH release in the culture medium was measured using CytoTox 96 
nonradioactive cytotoxicity assay kit according to the manufacturer’s protocol. 
Absorbance was read in BioTek Power Wave XS. 
To evaluate St-T1b cell proliferation after 48 h of treatment with anandamide, 
two tests were used: Sulphorhodamine B assay and Thymidine incorporation assay. 
Sulforhodamine B measures total protein content, while Thymidine incorporation assay 
measures the radioactive nucleoside, 3H-thymidine, that is integrated into new DNA. 
For both assays, cells were plated in 96-well plates as for cell viability experiments.  
In the sulphorhodamine B test, the medium was initially removed, cells were 
washed with PBS and fixed with trichloroacetic acid (4%) for 1 h on ice. After this 
period, plates were washed with PBS and air-dried at room temperature (RT). 
Sulpharhodamine B (0.4% (wt/vol) in 1% acetic acid) was added to each well and 
incubated for 30 min. After the incubation period, plates were quickly washed with 1% 
acetic acid, in order to remove unbound dye, and allowed to dry. Sulpharhodamine B 
was dissolved in tris-base (10 mM) and measured spectrophometrically (492 nm). 
Thymidine incorporation was assessed by the addition of 3H-thymidine (0.5 
µCi). Three different times (8, 18 and 24 hours) of incubation with 3H-thymidine were 
tested and 24 hours was selected. Thus, cells were treated for 48 h with AEA and in 
the last 24 h was added 3H-thymidine. After a cycle of freezing/ defrosting, cellular 
content was harvested using a semi automated cell harvester (Skatrum Instruments, 
Norway) into a specific filter. After addition of scintillation cocktail, 3H-thymidine 
incorporation was determined in a scintillation counter (LS 6500, Beckman 
Instruments, CA, USA). Results are expressed as relative percentage of the untreated 
control cells (100%). 
 
6 Morphological studies 
Morphological alterations induced by anandamide were evaluated by Giemsa 
and Hoechst staining. St-T1b cells and primary cells were plated at a density of 1.5 x 
104 cells/well in 24-well culture dishes and incubated for 48 h with different 
concentrations of AEA (1, 10 and 25 µM). After treatment, cells were fixed with 
methanol for 20 min on ice. 
The Giemsa staining was used to analyse cell morphology. After fixation, cells were 
stained with Giemsa diluted in water (1:10) for 30 minutes, washed with water and 
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mounted in DPX. Cells were observed under the microscope Eclipse E400, Nikon 
equipped with image analysis software LeicaQwin. It was counted 2500 cells per slide 
in five different experiments.  
To evaluate nuclear morphology, specifically chromatin condensation, cells were 
exposed to 0.5 mg/ml Hoechst 33258 in PBS for 20 minutes at room temperature, 
washed with PBS and mounted in fluoroshield. The cells were examined under a 
fluorescence microscope Nikon Eclipse Ci (Nikon, Tokyo, Japan) equipped with an 
excitation filter with maximum transmission at 360/400 nm and processed by Nikon NIS 
Elements v 4.0 software.  
 
7 Immunocytochemistry  
To determine the culture purity, vimentin, a fibroblastic cell marker, and 
cytokeratine, an epithelial cell marker, were localized by immunocytochemistry using 
an avidin–biotin alkaline phosphatase complex immunohistochemical technique  - 
VECTASTAIN ABC Kit. Primary cells were plated at a density of 1.5 x 104 cells/well in 
24-well culture dishes and incubated for three days. Medium was removed and cells 
were washed with PBS. Non-specific binding sites were blocked with diluted normal 
blocking serum for 20 minutes. Cells were incubated overnight with primary antibodies 
against vimentin (sc 6260; 1:500 dilution) from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA) and cytokeratin (M 7018; 1:100 dilution) from Dako (Glostrup, Denmark) at 
4ºC. After washing with PBS, cells were incubated with biotinylated secondary antibody 
for 30 minutes and then with Vectastain ABC-AP reagent. To initiate the reaction, 
alkaline phosphatase substrate solution Sigma Fast RedTM tablets was added. The 
slides were counterstained with Mayer’s hematoxylin solution and mounted in 
Aquamount. The choriocarcinoma cell line BeWo was used as a positive control for 
cytokeratine.  
 
8 Cell cycle analysis 
St-T1b cells were plated at a density of 17.5 x 104 cells in 25 cm3 culture flasks 
and incubated with AEA (10 µM) during 48 h. Cells were tripsinized, centrifuged (260 x 
g, 5 min, 4ºC), resuspended in 0.5 ml PBS and fixed in 70% cold ethanol for at least 2 
h. After fixation, cells were centrifuged and the pellet was washed three times with 
PBS. Cells were resuspended in 0.5 ml of DNA staining solution (5 mg/ml Propidium 
Iodide (PI), 0.1% Triton X-100 and 200 mg/ml Dnase-free Rnase A for 15 min at 37ºC. 
DNA content was analysed by flow cytometry based on the acquisition of 20 000 
events (with a threshold of 500 000) in a BD Accuri™ C6 (Becton–Dickinson, San 
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Jose, CA, U.S.A) equipped with BD Accuri C6 software. Detectors for the three 
fluorescence channels (FL-1, FL-2 and FL-3) and for forward (FSC) and side (SSC) 
light scatter were set on a linear scale. Debris, cell doublets and aggregates were 
gated out using a two-parameter plot of FL-2-Area to FL-2-Width of PI fluorescence. 
Data was analysed using FlowJo Software (Tree Star, Ashland, OR, USA). Assays 
were performed in duplicate in three independent experiments.  
 
9 Determination of caspase 3/7 activity 
The Caspase-Glo® 3/7 was used to evaluate caspase 3/7 activities according to 
the manufacturer’s protocol. St-T1b cells (2.5 x 103 cells/well) were incubated with 
anandamide (1 and 10 µM) for 36 h. As positive control, cells were incubated with 
Staurosporine (STS; 10 µM) for the last 3 hours of experiment. The resultant 
luminescence was measured in relative light units (RLU) using a 96-well Microplate 
Luminometer (BioTek Instruments, Winooski, VT, USA).  
 
10  Western blot 
 To identify CB1 and CB2 proteins in St-t1b it was performed a western blot. 
 St-T1b cells were cultured at a density of 5 x 104 cells/well in 24-well culture 
dishes. After treatment, medium was removed and cells were washed with phosphate 
buffered saline (PBS). Lysis Buffer and protease inhibitor cocktail (1:100) were added 
to each well, and incubated for 15 min on ice. Cells were scraped and subjected to 
three cycles of freezing/defrosting. The protein fraction (supernant) was obtained after 
centrifugation at 14000 x g for 10 min and stored at -80 ºC. Total protein concentration 
was measured using the Bradford assay.  
 Protein samples (50 µg) were prepared in sample buffer, boiled for 3 min to 
denature proteins and subjected to 10% SDS-polyacrylamide and then transferred onto 
nitrocellulose membranes for 2 h 30 min. Membrane was incubated for 1 h in blocking 
solution (5% non-fat milk in PBS 0.1% Triton) at RT and then with the primary antibody 
solution overnight at 4ºC with agitation. Western blots were performed with antibodies 
against CB1 (1:100) and CB2 (1:100) from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). After washing, the membrane incubated with peroxidase-conjugated secondary 
antibody at RT for 1 h. Finally, blots were visualized by chemiluminescence detection 
kit and exposed to x-ray film. Membranes were stripped and reprobed with anti-β-
tubulin antibody (1:500) to control loading variations. Brain and spleen tissue were 
used as a positive control for CB1 and CB2, respectively. 
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11 Quantitative Real-Time Polymerase Chain Reaction 
To unfold the effect of anandamide during the process of decidualization, cells 
were co-incubated with 0.5 mM 8-Br-cAMP and 1µM MPA and anandamide (1 µM and 
10 µM) for three days. The expression of the decidualization specific markers IGFBP1 
was assessed by real-time polymerase chain reaction (real time-PCR). Analysis of cell 
transcript was carried out by total RNA extraction and respective cDNA synthesis 
followed by real time-PCR. Reactions were run in duplicate and normalized to the 
housekeeping gene, β2-microglobulin. 
 
11.1 Isolation of total RNA from St-T1b cells 
Total RNA was isolated from St-T1b cells by using TRIsure. Medium was 
removed and 500 µl of TRIsure per well was added to lyse the cells. To each sample 
was added 200 µl of chloroform and centrifuged at 12000 x g for 15 min at 4ºC. The 
aqueous phase was transferred carefully and RNA was precipitated with 250 µl of cold 
isopropyl alcohol after centrifuging at 12000 x g for 10 min at 4ºC. Supernatant was 
removed and the pellet was washed with 500 µl of 75% ethanol and centrifuged at 
7500 x g for 5 min at 4 ºC. RNA was resuspended in Rnase free water and incubated 
for 10 min at 55 ºC to ensure it was completely solubilized.  
RNA was quantified by Nanodrop 1000 (Thermo Scientific, Wilmington, DE, USA) and 
its purity was assessed by absorbance 260/280 and 260/230 ratios. RNA was stored at 
-80ºC until reverse transcriptase reaction. 
 
11.2 Reverse transcriptase reaction: synthesis of cDNA  
In order to synthesise cDNA from previously extracted RNA, the iScript cDNA 
Synthesis Kit was used according to the manufacturer instructions. Per reaction were 
used 4 µl of 5x iScript reaction mix, 1 µl of iScript reverse trancriptase, 1 µg of total 
RNA and Rnase free water until adjust the volume to 20 µl. Reagents were mixed 
carefully and centrifuged briefly. The samples were finally placed in the T100 Thermal 
Cycler  (BioRad, Hercules, CA, USA) for the reverse transcriptase polymerase chain 
reaction (RT-PCR). DNA was stored at -20 ºC until Real time-PCR.  
11.3 Real time-PCR 
Real time-PCR of the previously synthesized cDNA was performed using the 
KAPA SYBR FAST qPCR Kit according to the manufacturer instructions. PCR mix was 
prepared in a 1.5 ml reaction tube by adding water, 1x KAPA SYBR FAST qPCR 
Master Mix (2x) Universal, 200 nM of each primer (Sigma-Aldrich Co., Saint Louis, MO, 
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USA), 1 µl of cDNA sample. Table 2 contains the information about primers sequence, 
accession number, annealing and melting temperature. Per reaction the final volume 
was set to 20 µl. The reaction plated was sealed, centrifuged briefly and placed in MJ 
Mini Thermal Cycler (BioRad, Hercules, CA, USA). 
 
Table 2. Information about primer sequence, gene accession number and Real time PCR conditions for each target 
gene. 
mRNA target 
GenBAnk 
accession 
no. 
Primes (5’-3’) 
Annealing 
temperature 
(ºC) 
Melting 
temperature 
(ºC) 
Sense TGCTGTCTCCATGTTTGATGTATCT Β2-
microglobulin 
NM 
004048.2 Antisense TCTCTGCTCCCCACCTCTAAGT 
59 80 
Sense GAGATAACTGAGGAGGAG 
IGFBP1 NM 000596 
Antisense CCAAAGGATGGAATGATC 
59 77 	  
 
13 Statistical analysis  
Statistical analysis was carried out by ANOVA, followed by the Bonferroni post 
hoc test to make pairwise comparisons of individual means (GraphPad PRISM v. 6.0, 
GraphPad Software, Inc., San Diego, CA, USA) when significance was indicated. The 
results are the mean of three independent experiments performed in triplicate. Data 
were expressed as mean±SEM and differences were considered to be statistically 
significant at P < 0.05.  
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III Results 
 
 
1 Non-differentiated cells 
 
1.1 Implementing cell line culture and further techniques 
At the time this study started, the work with the St-T1b cell line had been 
recently initiated. Therefore, it was put a great effort to establish the conditions for the 
culture of these cells including the ideal cell density, FBS concentration and number of 
cell passages that could be used.  Firstly, different concentrations of AEA were added 
to St-T1b cells cultured with 1 and 10% of FBS. With 10 % of FBS, AEA had no effect 
on these cells, so further studies were carried out using only 1% of FBS.  It was also 
observed that after the nineth trypsinization, cells started to react differently to the 
treatment with endocannabinoids. Henceforth, St-T1b experiments were set from the 
second to the nineth trypsinization. In addition, different times of incubation were tested 
(8, 16 and 24 h) with 3H-thymidine. Since the rate of proliferation was very low, it was 
chosen the 24 h for the thymidine incorporation assay. 
As referred in the literature, to study the decidualization process the cells 
should be treated with MPA and cAMP. However, in our experiments the cells were 
consistently dying. So, as MPA was firstly dissolved in ethanol, it was tested MPA 
dissolved in water, but no differences were observed. Several concentrations of cAMP 
(0.1; 0.25 and 0.5 mM) with or without MPA were tried out, but cells continued to dye. It 
was then verified that this effect was immediate and so it was hypothesized that 
perhaps it was not the cAMP effects but its solvent. The medium pH was measured 
before and after treatment and different values were recorded, with an acidification of 
the medium after treatment. Although DMEM-F12 contains HEPES buffer, it was not 
enough to immediately stabilize the pH differences. In order to solve this, the medium 
with 0.5 mM cAMP and 1 µM MPA was prepared previously, stabilized in the incubator 
and only after that added to St-T1b cells.  
This study also accompanied the establishment of primary cultures of term 
decidua fibroblasts. Different initial cell densities were tested, but it was concluded that 
the best option was to use the same as for St-T1b cell line. 
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1.2 Western blot analysis  
The presence of the cannabinoid receptors, CB1 and CB2, in St-T1b cell line 
was evaluated by western blot (Figure 8).  Results revealed that this cell line does 
express CB1. On the other hand, it was not detected the CB2 receptor protein, 
suggesting that St-T1b cell line might not express CB2.  
  
 
Figure 8. Cannabinoid receptors protein levels on St-T1b cell line. Representative western blots for CB1, CB2 and β-
tubulin of protein extracts from St-T1b cells. (PC – positive control).  
 
 
1.3 Cell viability   
To unveil the effects of AEA in St-T1b cell line, cell viability and cytotoxicity 
were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) and 
lactate dehydrogenase (LDH) release assays, respectively. AEA induced a reduction in 
cell viability in a dose-dependent manner between 10 and 50 µM. 
The exposure to 5 µM of AEA had no effect on cell viability. However, at 24 and 
48 h of treatment with 10 µM of AEA was observed a significant reduction of 19% in 
cell viability (p < 0.0001) (Figure 9A). After 24 h treatment with 25 and 50 µM, cell 
viability was reduced markedly to 50% and 30%, respectively.  
A significant increase in LDH release was only observed for AEA 
concentrations higher than 25 µM (Figure 9B). Thus, MTT and LDH results showed 
that treatment with 10 µM of AEA leads to cell viability loss without evidences of 
cytotoxicity. Therefore, further experiments were performed with the concentration of 
10 µM.  
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Figure 9. Effects of AEA on St-T1b cells viability. Cell viability of AEA-treated cells with different concentrations (0.01–
50 µM) and at different times (24, 48, 72 h) accessed by MTT assay (A) and LDH release (B). Results are expressed as 
mean ± SEM of three independent experiments performed in triplicate. Significant differences between control and AEA-
treated cells are denoted as **(p<0.01); ***(p<0.001) and ****(p<0.0001).  
 
To verify the involvement of the cannabinoid receptor CB1 in St-T1b cell death, 
CB1 was blocked with selective antagonist AM 251. After testing different 
concentrations of antagonist (0.1; 0.5 and 1 µM) the concentration used for the assays 
was of 0.1 µM. AM 251 did not prevent AEA-induced cell death (Figure 10).  
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Figure 10. The effect of cannabinoid receptor in AEA-induced cell death of St-T1b cell line. Cells were treated with 0.1 
µM AM 251, 10 µM AEA and antagonist plus anandamide. Results are expressed as mean ± SEM of three independent 
experiments performed in triplicate. Significant differences between control and AEA-treated cells are denoted as ** 
(p<0.01). 
 
1.4 Cell proliferation 
To analyse the effects on cell proliferation, sulphorhodamine B and thymidine 
incorporation assays were carried out. Sulphorhodamine B (Figure 11A) results 
showed that 1 µM of AEA had no effect on cell proliferation, whereas AEA at 
concentrations of 10 and 25 µM, induced about 22 and 50% decrease in cell 
proliferation, respectively. Besides sulphorhodamine B, it was also performed a 
thymidine incorporation assay (Figure 11B), which presented a much more dramatic 
effect of AEA in St-T1b cells proliferation. At 10 µM, AEA already decreased the rate of 
DNA synthesis to 53% and at 25 µM this effect was even more marked.  
 
	  
Figure 11. Effects of AEA on St-T1b proliferation assessed by sulphorhodamine B (A) and thymidine incorporation 
assay (B). Cell proliferation of St-T1b cells after 48 hours of treatment with different concentrations (1, 10 and 25 µM) of 
AEA. Results are expressed as mean ± SEM of three independent experiments performed in triplicate. Significant 
differences between control and AEA-treated cells are denoted as **(p<0.01) and **** (p<0.0001).  
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1.5 Morphological studies 
To investigate whether AEA treatment has an impact on St-T1b cell line 
morphology, cells were cultured for 48 h in the absence and presence of AEA (1 and 
10 µM) and examined by Giemsa and Hoechst staining (Figure 12). The most marked 
differences were observed with 10 µM of AEA. Giemsa staining showed that under 
treatment, cells preserved general morphology, though binucleate cells were observed. 
A slight decrease in cell density was also detected. Hoechst staining indicated the 
presence of a slight increase in chromatin condensation, indicative of a possible 
mechanism of apoptosis. Binucleate cells presented smaller nuclei with chromatin 
condensation. Treatment with 1 µM of AEA showed, although sparsely, the presence of 
binucleate cells and chromatin condensation.  
Through cell counting it was possible to confirm that after treatment with 10 µM, 
there was a significant increase of 10% of binucleate cells when compared to control 
(Figure 12G), while 1 µM of AEA did not lead to a significant increase in binucleate 
cells.  
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Figure 12. Effects of AEA on St-T1b cells morphology and binucleate cell counting. Giemsa staining (A, C and E) and 
Hoechst staining (B,D and F). Cells were incubated in the absence (A and B) and in the presence of 1 µM (C and D) or 
10 µM (E and F) of anandamide for 48 hours. Arrows correspond to binucleate cells. (Original magnification, x200). G – 
Binucleate cell counting. Results are expressed as mean ± SEM of five independent experiments, where 2500 cells 
were counted per slide. Significant differences between control and AEA-treated cells are denoted as **** (p<0.0001).  
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1.6 Cell cycle analysis 
To understand whether the reduction on cell viability and presence of 
binucleate cells was associated with an effect on cell cycle progression, DNA content 
was measured by flow cytometry (Table 3 and Figure 13). After 48 h of treatment, 
anandamide caused a significant cell cycle arrest in G2/M (7.07 ± 0.49%, p < 0.0001) 
when comparing to control (2.1 ± 0.17%). On the other hand, it was observed a 
decrease in the percentage of cells in G0/G1. While in control  96.52 ± 0.33% of cells in 
G0/G1 was registered. After treatment this number was reduced to 89.7 ± 1.01% (p < 
0.0001).  
 	  
Table 3. Effect of anandamide in different phases of cell cycle progression in St-T1b cells treated during 48 hours. 
Cells were treated with/without anandamide (10 µM). Treated cells were harvested, fixed and their DNA content was 
evaluated by PI labelling followed by flow cytometry analysis. Data are presented as single cell events in G0/G1, S and 
the G2/M phases of the cell cycle. Results are expressed as mean ± SEM of three independent experiments performed 
in duplicate. Significant differences between control and AEA-treated cells are denoted as **** (p<0.0001).  
 
 
	  
Figure 13. Representative histograms of cell cycle distribution of St-T1b cells control and treated with anandamide (10 
µM) for 48 h. Histograms were obtained with FlowJo Software (Tree Star, Inc) by the application of the Watson 
mathematical model and are representative of one independent assay. The numbers indicate the percentage of cells in 
each cell cycle phase. 
 
 
 
Cell cycle G0/G1 S G2/M 
Control 96.52 ± 0.33 2.08 ± 0.35 2.1 ± 0.17 
Treated 89.7 ± 1.01**** 2.26 ± 0.19 7.07 ± 0.49**** 
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1.7 Caspase 3/7 activity 
As described above, treated cells with AEA (10 µM) presented chromatin 
condensation in Hoechst staining, a feature of apoptosis. In order to confirm the 
occurrence of apoptosis, it was evaluated the activity of caspase 3/7 by luminescence 
(Figure 14). Treatment with AEA (10 µM) lead to an increase of 17% in caspase 3/7 
activity in comparison to the control cells (p < 0.5). The addition of AM 251 did not 
reverse the AEA-induced caspase 3/7 activity. STS was used as a positive control for 
apoptosis.  
 
	  
Figure 14. Caspase 3/7 activity of control and AEA-treated cells. Evaluation of caspase-3/7 activity in St-T1b cells after 
36 h of culture with AEA (10 µM) and AM 251. STS (10 µM) was a positive control. Results are expressed as mean ± 
SEM of three independent experiments performed in triplicate. Significant differences between control and AEA-treated 
cells are denoted as * (p<0.05) and **** (p<0.0001).  
 
1.8 Term decidua fibroblast cells viability 
To ascertain the purity of the primary culture, expression of the cytoskeletal 
proteins vimentin and cytokeratin was analysed by immunocytochemistry (Figure 15). 
Cell population from primary culture of term decidua fibroblast cells were positive for 
vimentin and did not express cytokeratin, an epithelial cell marker.  A choriocarcinoma 
cell line, BeWo cell line, was used as a positive control for cytokeratin. 
To evaluate cell viability, MTT and LDH assays were performed as shown 
previously for St-T1b cell line (Figure 16). AEA induced a reduction in cell viability in a 
dose- and time-dependent manner. A significant loss in cell viability to 83.6% was 
observed for the concentration of 10 µM and after 48 hours of treatment (p < 0.001). 
Between 10 and 25 µM this effect was drastic with a decrease in cell viability to 26% at 
24 hours of treatment with 25 µM. LDH release was similar to the observed for the St-
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T1b cell line. A cytotoxic effect was observed after 24 h of treatment with 25 µM of 
AEA.  
 
 
	  
Figure 15. Detection of cytoskeletal proteins by immunocytochemistry. A - Term decidua fibroblast cells were positive 
for vimentin and negative (B) for cytokeratine. C - The choriocarcinoma BeWo cell line was used as a positive control for 
cytokeratine. (A1 - negative control; original magnification, x400). 
 
 
 
 
 
	  
Figure 16. Effects of AEA on term decidua fibroblast cells (A and B) viability estimated by MTT assay and LDH release. 
Cell viability of AEA-treated cells with different concentrations (0.01–50 µM) and at different times (24, 48, 72 h) 
assessed by MTT assay (A) and LDH release (B). Results are expressed as mean ± SEM of three independent 
experiments performed in triplicate. Significant differences between control and AEA-treated cells are denoted as 
***(p<0.001) and **** (p<0.0001).  
FCUP 
The effect of the endocannabinoid anandamide on human endometrial stromal cells 
40	  
 
1.9 Term decidua fibroblast cells morphology 
The effect of AEA on term decidua fibroblast cells morphology was determined 
by Giemsa and Hoechst staining (Figure 17). Cells were treated with 1 and 10 µM of 
AEA for 48 hours and compared to control. In the control condition, cells presented a 
confluence of about 90% with an elongated morphology. It was possible to observe a 
scarce number of binucleate cells. The treatment with 1 µM of AEA showed a very 
similar morphology to the control. It was not denoted a decrease in cell number and 
there was still some dispersed binucleate cells. Treatment with 10 µM of AEA led to 
marked alterations. It was detected a decrease in cell density and a larger quantity of 
binucleate cells, although general morphology was not affected.   
Similar to St-T1b cell line, hoechst staining showed an increase of chromatin 
condensation after treatment with AEA. At 1 µM of AEA this effect was still not marked.  
Although the presence of binucleate cells was already detected in the control, 
AEA-treated cells (10 µM) showed an increase of 6% (Figure 17G). 
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Figure 17. Effects of AEA on term decidua fibroblast cells morphology and binucleate cell counting. Giemsa staining (A, 
C and E) and Hoechst staining (B,D and F). Cells were incubated in the absence (A and B) and in the presence of 1 µM 
(C and D) or 10 µM (E and F) of anandamide for 48 hours. Arrows correspond to binucleate cells. (Original 
magnification, x200). G - Binucleate cell counting. Results are expressed as mean ± SEM of five independent 
experiments, where 2500 cells were counted per slide. Significant differences between control and AEA-treated cells 
are denoted as **** (p<0.0001). 
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2 Differentiated cells 
 
2.1 Efficiency of cAMP, forskolin or prostaglandin E2 in decidualization  
When compared to non-decidualized St-T1b cells, each of the experimental 
conditions showed morphological differences (Figure 18). After treatment with cAMP, 
cells became larger and rounder, typical characteristics of decidualized cells. Through 
Giemsa staining it was possible to observe that nuclei acquired a rounder morphology. 
Cells under treatment with forskolin also showed morphological differences, though 
cells were still slightly more elongated than with cAMP. Although prostaglandins and 
estradiol induced to some extent a round cellular shape, it was the treatment that most 
resembled the non-decidualized control.  
The various differentiation treatments presented a reduced cell number, when 
compared to the non-decidualized situation. However, between cAMP, forskolin and 
PGE2 + E2 it was possible to denote differences, where cAMP had a lower number of 
cells than prostaglandins and estradiol conditions.  
IGFBP1 mRNA levels were also evaluated as a biochemical marker of 
decidualization (Figure 19). While PGE2 + E2 showed similar levels  to the non-
decidualized control, forskolin induced an increase in IGFBP1 though these were not 
considered statistically significant. On the other hand, cAMP was the only 
differentiation factor to induce a statistically significant increase in IGFBP1 mRNA 
levels. Thus, these results indicate that cAMP + MPA was the most efficient treatment 
to induce decidualization of St-T1b and was henceforth used in the following 
experiments.  
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Figure 18. Effects of various differentiation molecules on St-T1b cells morphology. Phase contrast microscopy  (A, C, E 
and G) and Giemsa staining (B, D, F and H). Non-differentiated cells (A and B) compared with cAMP + MPA (C and D); 
Forskolin + MPA (E and F) and PGE2 + MPA + E2 (G and H). (Original magnification, x100) 
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Figure 19. Transcript levels of IGFBP1 in St-T1b cells treatment with various differentiation molecules. cAMP was the 
most efficient treatment. All numerical data are expressed as mean ± SEM against control and differences were 
considered to be statistically significant when P<0.05. 
 
2.2 Effect of AEA on decidualization 
Although these experiments are still not concluded, preliminary results indicate 
that AEA caused an effect in the differentiation of St-t1b cell as assessed by the 
expression of the decidual marker IGFBP1 (Figure 20).  AEA at a concentration of 10 
µM induced a decrease in IGFBP1 mRNA when compared to the cells cultured in the 
absence of AEA, while 1 µM AEA had no negative impact on decidualization.  
 
	  
Figure 20. Preliminary results for the effect of AEA on St-T1b cell line differentiation. 
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IV Discussion 
 
 
The uterus undergoes cyclic morphological and physiological changes with the 
sole purpose of creating a suitable environment for implantation of the blastocyst.  
Under the influence of ovarian steroids, the endometrium is subjected to the processes 
of proliferation and differentiation culminating in specific period of receptivity. In 
addition, endocannabinoids are new lipid mediators involved in reproduction namely, in 
folliculogenesis, embryo transport through the oviduct and the establishment of a 
receptive endometrium. Thus, the aim of this work was to clarify what is the impact of 
AEA on human endometrial stromal cells and whether a deregulation of the 
endocannabinoid system might affect the proliferation and differentiation of these cells.  
Our results showed that AEA induced a reduction in cell viability, which might 
be elicited by an anti-proliferative effect and/or the induction of apoptosis. To test the 
effect on St-T1b cells proliferation, it was used the sulforhodamine B and the thymidine 
incorporation assays. Sulforhodamine B measures total protein content and does not 
distinguish between viable and dead cells (121), while thymidine incorporation assay 
measures directly DNA synthesis. Although both techniques have been broadly used to 
study proliferation during the last few years, the thymidine incorporation assay is more 
accurate. The results obtained by these two methods showed undoubtedly that 
anandamide has an anti-proliferative effect on endometrial stromal cell line, which is in 
accordance to other studies that reported AEA as an anti-proliferative agent in different 
cell types. On cholangiocarcinoma cell lines Mz-ChA-1, HuCCT-1, CCLP-1 and 
SG231, anandamide exert an anti-proliferative effect by activation of GPR55 (122), 
while in neuroblastoma cells this effect was achieved through a lipid raft-dependent 
mechanism (123).  
Based in this anti-proliferative effect there is an emergent research area that 
studies the potential benefit of designing novel anti-cancerous therapies in association 
with endocannabinoids. In fact, the modulation of endocannabinoids has been implied 
as a resource for novel therapies in steroid hormone-dependent cancers, such as 
breast, prostate and endometrial cancer (124).	   This anti-proliferative effect has also 
been reported as a promising approach in the treatment of endometriosis (110), a 
common disease characterized by the presence of endometrial tissue outside of the 
uterine cavity. 
In addition, the decrease in cell proliferation was not the only action exerted by 
AEA on St-T1b cells. Hoechst staining revealed that this endocannabinoid could also 
induce chromatin condensation, a feature of apoptotic process. There are two main 
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apoptotic pathways: the extrinsic or death receptor pathway and the intrinsic or 
mitochondrial pathway. Both pathways end at the point of the execution phase, when 
effector caspases 3/7 are activated. In turn, effector caspases activate cytoplasmic 
endonuclease, which degrade nuclear material, and proteases that degrade the 
nuclear and cytoskeletal proteins (125). To confirm the occurrence of apoptosis it was 
evaluated the activity of caspases 3/7 after 36 hours of treatment with AEA. It was 
observed an increase of 17% when compared to control, confirming the induction of 
apoptosis. 
Apoptosis has been identified at three different phases of the menstrual cycle, 
namely the early proliferative, late secretory, and menstrual phases (126). Hence, 
apoptotic cells were not detected during the late proliferative phase until the 
midsecretory phase. At the beginning of the late secretory phase, apoptosis in the 
stromal cells spreads gradually to almost all components of the functional layer (126). 
Thus, this programmed cell death might be an important mechanism in the regulation 
of the menstrual cycle in women. Since anandamide levels are higher in proliferative 
phase than in secretory phase (127), this endocannabinoid might be related with the 
control of apoptosis throughout the menstrual cycle. On the other hand, the decreased 
endocannabinoid tone during the “window of implantation” is attributed to the maximal 
expression of degradation enzymes in the secretory phase (128). Thus, a disruption of 
the ECS with an alteration of synthesis/degradation pathways, may affect adversely the 
endometrial stromal layer. This could have a negative impact for the success of 
implantation, since it would alter the uterine environment.  
In addition, it was also demonstrated that the reduction in cell viability is 
independent of cannabinoid receptor, CB1, which is in accordance with some studies 
already published. Maccarrone et al., described that AEA induces apoptosis in human 
neuroblastoma CHP100 and lymphoma U937 cells via vanilloid receptors and assigned 
a protective role to cannabinoid receptors (93). On the other hand, membrane lipid 
rafts have been implicated in AEA-induced cell death, in a mechanism independent of 
cannabinoid or vanilloid receptors (89).  
Surprisingly, by light microscopy it was observed the presence of binucleated 
cells after AEA treatment, corresponding to 10 % of total population. Since, AEA had 
an antiproliferative effect and simultaneously led to the presence of binucleate cells it 
was investigated what was the real impact of this endocannabinoid in the cell cycle 
regulation. Thus, by flow cytometry, it was shown that AEA promoted a significant cell 
cycle arrest in G2/M phase. Compared to control, the cell population at the G2/M phase 
after treatment was approximately 3 times fold, being accompanied by a decrease in 
G0/G1 phase. These results revealed that the anti-proliferative effects of anandamide 
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are essentially due to the retention in G2/M, which prevents cells to enter in the G1 
phase. Several natural and synthetic (endo)cannabinoids have been described to 
inhibit cell proliferation, arrest the cell cycle and induce cell death, mainly through 
apoptosis and autophagy (129). In gastric cancer cells, treatment with AEA led to 
retention in G2/M phase and a subsequent increase in apoptosis (130). The same 
result was observed in breast cancer cells after treatment with THC (131). 
Cytokinesis is a highly ordered process, requiring an intricate interplay between 
cytoskeletal, chromosomal, and cell cycle regulatory pathways (132). To determine 
whether AEA-induced binucleated cells formation was due to inhibition of cytokinesis, it 
would be important to monitor the re-organization of microfilaments and microtubules 
proteins, actin and tubulin, respectively. Also, one of the central regulators of 
cytokinesis is the small GTPase RhoA and it has been extensively described that 
defects in Rho signalling is one of the mechanisms that results in cytokinesis failure 
(132,133). 
Cytokinesis arrest and consequent binucleate cells have been associated with 
DNA damage and programmed cell death (134). By contrast, differentiation of 
hepatocyte progenitor cell line, Lig-8, into mature hepatocytes is defined by 
binucleation (135). Following this line of thought, it has been suggested that AEA, in rat 
adipocytes, regulates cell differentiation (136). AEA increased adipocyte differentiation 
in primary cell cultures in a concentration- and time- dependent manner and induced 
PPARγ2, CB1, FAAH, and COX-2 expression (136).  In fact, the presence of 
binucleate cells has been reported in human decidualization (39), though their 
importance has never been addressed. In rodents, stromal cell polyploidy during 
decidualization limits the life span of decidual cells for the accommodation of the 
growing embryo (137). On the other hand, polyploidization is a feature of terminal 
differentiation (decidualization) and though it can be induced by multiple pathways, like 
apoptosis, immune system, mitochondrial function and tumors, the polyploidization of 
stromal cells is an elaborate regulatory system (138). For instance, in mice, the DEDD 
protein is involved in the induction of apoptosis and at the same it has been implicated 
in decidual cell polyploidization, being highly expressed at G2/M phase (138). The low 
levels of AEA at the time of implantation are important for the endometrium receptivity, 
implying that the presence of binucleate cells prior to the time of decidualization might 
jeopardize this process.  
In addition, primary cell culture had results consistent with St-T1b cell line. AEA 
induced a loss of cell viability and led to a significant increase of binucleate cells. 
However, contrary to St-T1b cell line, term decidua fibroblast cells also presented 
binucleate cells in the absence of AEA. After mid-pregnancy despite high levels of 
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circulating progesterone the decidua begins a slow process of regression, which 
continues to term. In rat, this regression is characterized by an increase of proteins that 
promote apoptosis such as p27, Bax and caspase-3 (139). Thus, term placenta was 
exposed to the processes of differentiation, proliferation, regression and apoptosis and 
additionally to anandamide levels throughout pregnancy, which might explain the 
presence of these binucleate cells.  
In this work we were also interested to understand the AEA effect during the 
differentiation of stromal to decidual cells, a process designated decidualization. First 
were tested multiple inducing treatments. cAMP was the most efficient as revealed by 
the alterations in morphology and expression of IGFBP1, a biochemical decidual 
marker, followed by forskolin and PGE2 morphological and biochemical markers 
followed by forskolin and PGE2. Although PGE2 is known to induce differentiation of 
primary cultures (140), the St-T1b cells revealed a weak degree of differentiation. 
Forskolin, which is an agent able to enhance cAMP levels (141), showed marked 
morphological changes accompanied by an increase in the expression of biochemical 
markers. These results confirmed that St-T1b differentiation could respond to different 
conditions, though with different intensities.  
Preliminary experiments indicated that AEA might inhibit the process of 
decidualization as shown by the decrease of the expression of IGFBP1, a decidual 
marker. Kessler et al, associated this effect to the activation of CB1 and stimulation of 
apoptosis by a cAMP dependent mechanism (113).  
 
In summary, the work developed in the scope of this thesis may serve as basis 
for understanding the effect of AEA on human endometrial stromal cells. It was 
established that this endocannabinoid is responsible for an anti-proliferative and 
apoptotic outcome. It leads also to a significant increase of binucleate cells. 
Nevertheless, it is still required to investigate the mechanism behind the AEA- induced 
apoptosis and the presence of binucleate cells. Since the process of decidualization is 
a prerequisite for a successful pregnancy and the majority of this work was performed 
in non-differentiated cells, it is imperative to continue and reproduce these experiments 
in the differentiation process. This would enable to explore if differentiated cells 
enhance the protection of stromal layer against anandamide deregulation.  
Furthermore, these results indicate that a tight AEA levels modulation is crucial 
for women cyclic endometrial preparation for pregnancy. However, a bigger issue is 
imposed when we consider that recent studies demonstrate that THC and other 
exogenous cannabinoids exert potent effects on the ECS homeostasis. Cannabis is 
one of the most consumed illicit drugs worldwide and a peak of drug usage is 
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registered among 18 and 25 years old women. This fact is of great concern, since it 
might be behind for one of the reasons of idiopathic infertility, which is diagnosed in 
15% to 30% of couples. If cannabis use alters the ECS, including metabolism 
enzymes, then, it will ultimately interfere with endocannabinoids levels and possibly 
with female fertility.  
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